Pharmaceutically important pre- and posttranslational modifications on human serum albumin
Masaki Otagiri1, Victor Tuan Giam Chuang
1Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Japan. otagirim@gpo.kumamoto-u.ac.jp
Biological & Pharmaceutical Bulletin
|April 2, 2009
Summary
Recombinant human serum albumin is a key drug carrier. Understanding genetic variations and posttranslational modifications like oxidation and glycation is crucial for designing effective albumin-based therapeutics.
Area of Science:
- Biotechnology
- Protein Engineering
- Pharmacology
Background:
- Recombinant technology enables the production of engineered proteins with specific functions.
- Human serum albumin (HSA) produced via recombinant technology is increasingly utilized as a drug carrier in clinical applications.
- Genetic variations in HSA typically reside on the protein surface and may influence drug binding, particularly fatty acid interactions.
Purpose of the Study:
- To review the impact of genetic variations and posttranslational modifications on human serum albumin.
- To provide insights for designing albumin mutant analogues with improved pharmaceutical properties.
Main Methods:
- Literature review on recombinant technology, HSA genetics, and posttranslational modifications.
- Analysis of how genetic variations affect albumin's conformation and fatty acid binding.
- Examination of major posttranslational modifications: oxidation, glycation, and S-nitrosylation.
Main Results:
- Genetic variations on HSA surface may alter fatty acid binding without significantly affecting overall protein conformation.
- Oxidation, glycation, and S-nitrosylation are key posttranslational modifications impacting albumin function.
- Consideration of these modifications is essential for rational design of albumin-based drug delivery systems.
Conclusions:
- Designing effective recombinant albumin analogues requires a comprehensive understanding of both genetic and posttranslational modifications.
- Tailoring albumin variants for drug delivery necessitates careful evaluation of how these modifications influence protein-ligand interactions and stability.
Related Concept Videos
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
01:29Drug Distribution: Plasma Protein Binding
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
01:02Phosphorylation
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
01:19Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme activation, sulfur...
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...